You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
PUUILO Q1: Exemplary performance
Puuilo’s Q1 left no doubts: strong growth in customer numbers, combined with high profitability, with an expected improvement in gross-margin. Analyst Arttu Heikura summarizes.
Content:
00:00 Intro
00:15 Typical location for a Puuilo store
00:39 Q1 highlights
01:15 Profitability
02:01 Valuation
Herantis Pharma as an Investment | Life Science Night Dec. 2, 2024
Aiforia as an Investment | Life Science Night Dec. 2, 2024
Faron Pharmaceuticals as an Investment | Life Science Night Dec. 2, 2024
Life Science Companies as Investments | Life Science Night Dec. 2, 2024
Life Science Night | December 2, 2024
Titta på alla videor